Dan Kawamori

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Molecular pathways underlying the pathogenesis of pancreatic alpha-cell dysfunction
    Dan Kawamori
    Department of Cellular and Molecular Physiology, Joslin Diabetes Center, and Department of Medicine, Harvard Medical School, Boston, MA, USA
    Adv Exp Med Biol 654:421-45. 2010
  2. ncbi The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells
    Chong Wee Liew
    Section of Islet Cell and Regenerative Medicine, Department of Medicine, Harvard Medical School, Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215, USA
    J Clin Invest 120:2876-88. 2010
  3. ncbi Insulin modulation of glucagon secretion: the role of insulin and other factors in the regulation of glucagon secretion
    Dan Kawamori
    Department of Cellular and Molecular Physiology, Harvard Medical School, Boston, MA USA
    Islets 1:276-9. 2009
  4. ncbi Insulin signaling in alpha cells modulates glucagon secretion in vivo
    Dan Kawamori
    Department of Cellular and Molecular Physiology, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA
    Cell Metab 9:350-61. 2009
  5. ncbi Δ40 Isoform of p53 controls β-cell proliferation and glucose homeostasis in mice
    Charlotte Hinault
    Research Division, Joslin Diabetes Center and Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Diabetes 60:1210-22. 2011
  6. ncbi Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance
    Chong Wee Liew
    Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA
    Nat Med 19:217-26. 2013
  7. ncbi Liver-derived systemic factors drive β cell hyperplasia in insulin-resistant states
    Abdelfattah El Ouaamari
    Section of Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center and Harvard Medical School, Boston, MA 02115, USA
    Cell Rep 3:401-10. 2013

Collaborators

  • Rohit N Kulkarni
  • Matthias Bluher
  • Yu Hua Tseng
  • Amy J Wagers
  • LAURIE GOODYEAR
  • Colin A Leech
  • Hannah J Welters
  • Chong Wee Liew
  • Jiang Hu
  • Abdelfattah El Ouaamari
  • Charlotte Hinault
  • Stephen I Hong Hsu
  • Kristy Townsend
  • Dominique Langin
  • Marc K Hellerstein
  • Stephen R Farmer
  • Hitoshi Katsuta
  • Cecile Vernochet
  • Cristina Mallol
  • Wei Jun Qian
  • Ho Jin Koh
  • Jennifer L Shadrach
  • Jeremie Boucher
  • Alessandro Doria
  • Jennifer Hollister-Lock
  • Ercument Dirice
  • Jit Kong Cheong
  • Heidi Scrable
  • Bernhard Maier
  • Raghavendra G Mirmira
  • Susanna R Keller
  • Jacek Bochenski
  • Ling Qi
  • James H Warram
  • Krzysztof Wanic
  • Andrzej S Krolewski
  • Maciej Malecki

Detail Information

Publications7

  1. ncbi Molecular pathways underlying the pathogenesis of pancreatic alpha-cell dysfunction
    Dan Kawamori
    Department of Cellular and Molecular Physiology, Joslin Diabetes Center, and Department of Medicine, Harvard Medical School, Boston, MA, USA
    Adv Exp Med Biol 654:421-45. 2010
    ..Therefore, understanding the molecular mechanism of how glucagon secretion is regulated is critical for treating the alpha-cell dysfunction observed in diabetes...
  2. ncbi The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells
    Chong Wee Liew
    Section of Islet Cell and Regenerative Medicine, Department of Medicine, Harvard Medical School, Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215, USA
    J Clin Invest 120:2876-88. 2010
    ..These data link a missense polymorphism in human TRB3 to impaired insulin exocytosis and thus increased risk for T2DM...
  3. ncbi Insulin modulation of glucagon secretion: the role of insulin and other factors in the regulation of glucagon secretion
    Dan Kawamori
    Department of Cellular and Molecular Physiology, Harvard Medical School, Boston, MA USA
    Islets 1:276-9. 2009
    ....
  4. ncbi Insulin signaling in alpha cells modulates glucagon secretion in vivo
    Dan Kawamori
    Department of Cellular and Molecular Physiology, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA
    Cell Metab 9:350-61. 2009
    ..Together, these data indicate a significant role for intraislet insulin signaling in the regulation of alpha cell function in both normo- and hypoglycemic conditions...
  5. ncbi Δ40 Isoform of p53 controls β-cell proliferation and glucose homeostasis in mice
    Charlotte Hinault
    Research Division, Joslin Diabetes Center and Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Diabetes 60:1210-22. 2011
    ....
  6. ncbi Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance
    Chong Wee Liew
    Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA
    Nat Med 19:217-26. 2013
    ....
  7. ncbi Liver-derived systemic factors drive β cell hyperplasia in insulin-resistant states
    Abdelfattah El Ouaamari
    Section of Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center and Harvard Medical School, Boston, MA 02115, USA
    Cell Rep 3:401-10. 2013
    ..These data implicate the liver as a critical source of β cell growth factor(s) in insulin-resistant states...